Interview with CEO and Co-Founder of Animatus Biosciences, Stephen Navran, Ph.D.

Animatus Biosciences is a Houston, Texas based development-stage biotech company developing regenerative therapeutics based on their unique modified mRNA platform. The company’s therapeutic candidate is a novel combination of 2 mutant mRNAs, which activate growth in otherwise non-replicating cells. This can be used to regenerate damaged or aged tissues. The first application is to regenerate heart tissue after a cardiac infarct. Heart failure is the single most serious health problem in the world today and the ability to regenerate failing hearts would make a huge difference in amelioration of suffering from cardiac infarct.